"Intraosseous administration of tenecteplase for thrombolysis of an acute ischemic stroke"

JinJoo Chung,Jonathan Bundy,Sameera Khan,Aaron Hunt,Seth Carroll,Aisha Ali,Neelofer Shafi,Eljim Tesoro
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107850
Abstract:Intro: Current guidelines for acute ischemic stroke recommend timely administration of intravascular thrombolytic therapy to promote functional and neurologic outcomes. Tenecteplase is an emerging off-label therapy for this indication and being utilized by various institutions due to its simpler administration strategy. In emergent situations in which intravenous access cannot be obtained, intraosseous access is a viable option for medication administration. However, there has been minimal published cases to support the efficacy and safety of intraosseous administration of tenecteplase for acute ischemic stroke. Case: We describe the case of a 51-year-old woman who developed acute ischemic stroke within our institution. Due to difficulty achieving intravenous access and time-dependent efficacy of thrombolytic therapy, the decision was made to administer tenecteplase by the intraosseous route. Stroke symptoms improved within 48 hours following administration without complication. Conclusion: Intraosseous administration of tenecteplase may be considered for treatment of acute ischemic stroke if intravenous access is unattainable.
What problem does this paper attempt to address?